Amalgamated Bank Regenxbio Inc. Transaction History

Amalgamated Bank

$11.7 Billion
Q1 2025

A detailed history of Amalgamated Bank transactions in Regenxbio Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,589 shares of RGNX stock, worth $13,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,589

Previous 1,359 16.92%

Holding current value

$13,284

Previous $11,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$5.92 - $8.7 $1,361 - $2,000	230 Added 16.92%	1,589 $11,000
Q4 2024 Feb 04, 2025	SELL	$7.23 - $11.56 $86,015 - $137,529	-11,897 Reduced 89.75%	1,359 $11,000
Q3 2024 Oct 30, 2024	SELL	$10.49 - $14.39 $3,744 - $5,137	-357 Reduced 2.62%	13,256 $139,000
Q2 2024 Aug 12, 2024	BUY	$11.51 - $21.53 $14,122 - $26,417	1,227 Added 9.91%	13,613 $159,000
Q1 2024 Apr 23, 2024	SELL	$12.17 - $24.61 $26,749 - $54,092	-2,198 Reduced 15.07%	12,386 $261,000
Q4 2023 Feb 06, 2024	SELL	$12.89 - $20.82 $25,457 - $41,119	-1,975 Reduced 11.93%	14,584 $262,000
Q3 2023 Nov 08, 2023	BUY	$16.46 - $19.99 $18,649 - $22,648	1,133 Added 7.34%	16,559 $273,000
Q2 2023 Aug 11, 2023	SELL	$17.23 - $21.71 $9,252 - $11,658	-537 Reduced 3.36%	15,426 $308,000
Q1 2023 May 02, 2023	SELL	$18.08 - $24.55 $24,227 - $32,897	-1,340 Reduced 7.74%	15,963 $302,000
Q3 2022 Nov 09, 2022	BUY	$22.29 - $35.04 $156 - $245	7 Added 0.04%	17,303 $457,000
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $10,797 - $19,552	-558 Reduced 3.13%	17,296 $427,000
Q1 2022 Jun 30, 2022	SELL	$24.62 - $34.31 $25,161 - $35,064	-1,022 Reduced 5.41%	17,854 $593,000
Q4 2021 Feb 15, 2022	SELL	$30.19 - $40.28 $7,939 - $10,593	-263 Reduced 1.37%	18,876 $617,000
Q3 2021 Oct 29, 2021	BUY	$29.09 - $45.68 $9,134 - $14,343	314 Added 1.67%	19,139 $802,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $611,059 - $762,035	18,825 New	18,825 $731,000
Q1 2021 May 13, 2021	SELL	$33.61 - $49.95 $187,711 - $278,970	-5,585 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $148,114 - $275,619	5,585 New	5,585 $253,000
Q3 2020 Oct 30, 2020	SELL	$27.01 - $40.26 $154,686 - $230,569	-5,727 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$27.75 - $43.44 $13,653 - $21,372	-492 Reduced 7.91%	5,727 $211,000
Q1 2020 May 13, 2020	SELL	$21.5 - $54.2 $4,665 - $11,761	-217 Reduced 3.37%	6,219 $201,000
Q4 2019 Feb 13, 2020	BUY	$34.54 - $44.87 $8,773 - $11,396	254 Added 4.11%	6,436 $264,000
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $2,101 - $3,358	-66 Reduced 1.06%	6,182 $220,000
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $46,914 - $66,226	1,117 Added 21.77%	6,248 $321,000
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $6,735 - $10,304	165 Added 3.32%	5,131 $294,000
Q4 2018 Feb 15, 2019	BUY	$39.11 - $75.15 $194,220 - $373,194	4,966 New	4,966 $208,000
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $300,430 - $379,697	-4,622 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$27.2 - $74.35 $125,718 - $343,645	4,622 New	4,622 $332,000

Others Institutions Holding RGNX

# of Institutions

182

Shares Held

45.4M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $361M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Regenxbio Inc. Transaction History